Fluvalinate
|
WikiDoc Resources for Fluvalinate |
|
Articles |
|---|
|
Most recent articles on Fluvalinate Most cited articles on Fluvalinate |
|
Media |
|
Powerpoint slides on Fluvalinate |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Fluvalinate at Clinical Trials.gov Clinical Trials on Fluvalinate at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Fluvalinate
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Fluvalinate Discussion groups on Fluvalinate Patient Handouts on Fluvalinate Directions to Hospitals Treating Fluvalinate Risk calculators and risk factors for Fluvalinate
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Fluvalinate |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
- Fluvalinate (trade names include Apistan, Klartan, Minadox) is a synthetic pyrethroid commonly used to control Diseases of the varroa mites in honey bee colonies.
- Fluvalinate is a stable, non-volatile, fat-soluble compound. Although the compound may be found in drones, a study has found honey samples virtually absent of fluvalinate, on account of its affinity to beeswax.[1]
- Tau-fluvalinate (τ-fluvalinate) is the trivial name for (2R)-fluvalinate. The C atom in the valinate structure is in D-configuration, while the second chiral atom is a mixture of both R and S.
See also
References
- ↑ A Review of Treatment Options for Control of Varroa Mite in New Zealand http://www.biosecurity.govt.nz/pests-diseases/animals/varroa/paper/varroa-treatment-options.htm#4 MAF Biosecurity New Zealand